FIELD: biotechnology.
SUBSTANCE: inventions relate to a method for construction of an Fv library, a method for screening of the desired antibody using this constructed Fv library, and an Fv library constructed by the method for Fv library construction. The presented method for Fv library construction includes the steps of: (a) preparation of proteins of the heavy chain variable region domain (VH), expressed in cells, and proteins of the light chain variable region domain (VL) expressed in cells; (b) pairing of the VH domain proteins and VL domain proteins, prepared in step (a), outside the cell, to form collected Fv; and (c) storage of the collected Fv from step (b) in individual compartmentswith individual identification numbers, the function of each individual Fv in individual compartments is analyzed without prescreening based on binding to the target.
EFFECT: inventions allow to significantly reduce the number of protein purification processes, thus reducing costs and time spent in comparison with conventional DNA-based libraries.
17 cl, 31 dwg, 4 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CLEANING PROTEIN INCLUDED IN SELF-IMMOLATIVE TAPE AND ITS APPLICATION | 2014 |
|
RU2639527C2 |
ANTAGONISTS AND METHOD OF USING SAID ANTAGONISTS | 2005 |
|
RU2401842C2 |
BINDING ELEMENTS WITH MODIFIED DIVERSIFIED BACKBONE DOMAINS | 2017 |
|
RU2778694C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2011 |
|
RU2774414C2 |
ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2649368C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2011 |
|
RU2663123C2 |
ANTIBODIES BOUND TO EXTRACELLULAR DOMAIN OF TYROSINE KINASE RECEPTOR (ALK) | 2007 |
|
RU2460540C2 |
THERAPEUTIC DLL4-BINDING PROTEINS | 2011 |
|
RU2605928C2 |
ANTIBODIES AGAINST HUMAN CD19 WITH HIGH AFFINITY | 2016 |
|
RU2761077C1 |
THERAPEUTIC DLL4-BINDING PROTEINS | 2010 |
|
RU2570639C2 |
Authors
Dates
2017-12-21—Published
2014-01-24—Filed